HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eiichi Nakayama Selected Research

Adenocarcinoma

1/2016Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
2/2011Isolation and characterization of human lung cancer antigens by serological screening with autologous antibodies.
8/2008Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens.
8/2005XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
2/2004Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eiichi Nakayama Research Topics

Disease

60Neoplasms (Cancer)
06/2017 - 05/2002
27Testicular Neoplasms (Testicular Cancer)
06/2017 - 12/2003
10Lung Neoplasms (Lung Cancer)
11/2014 - 02/2004
8Adenocarcinoma of Lung
12/2016 - 02/2004
7Melanoma (Melanoma, Malignant)
03/2014 - 10/2008
7Prostatic Neoplasms (Prostate Cancer)
11/2013 - 07/2003
6Esophageal Neoplasms (Esophageal Cancer)
10/2015 - 10/2004
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2016 - 08/2005
5Adenocarcinoma
01/2016 - 02/2004
5Pneumonia (Pneumonitis)
01/2008 - 01/2003
4Leukemia
11/2008 - 05/2002
4Infections
11/2008 - 05/2003
3Fever (Fevers)
05/2017 - 12/2011
3Injection Site Reaction
05/2017 - 12/2011
3Disease Progression
11/2013 - 04/2006
3Rabies (Hydrophobia)
02/2012 - 02/2010
3Ovarian Neoplasms (Ovarian Cancer)
11/2008 - 01/2004
2Chronic Hepatitis (Chronic Active Hepatitis)
06/2014 - 08/2006
2Hepatitis
01/2014 - 05/2003
2Hepatocellular Carcinoma (Hepatoma)
08/2006 - 05/2003
2Liver Neoplasms (Liver Cancer)
11/2005 - 01/2005
2Sarcoma (Soft Tissue Sarcoma)
11/2003 - 05/2003
1Type 2 Diabetes Mellitus (MODY)
02/2015
1Chronic Hepatitis C
06/2014
1Hepatitis C
06/2014
1Rupture
03/2014
1Hepatitis B
12/2013
1Hyperthermia
06/2013
1Experimental Melanoma
06/2013

Drug/Important Bio-Agent (IBA)

47AntigensIBA
06/2017 - 05/2003
21Proteins (Proteins, Gene)FDA Link
05/2017 - 01/2004
16Messenger RNA (mRNA)IBA
11/2008 - 07/2003
12Peptides (Polypeptides)IBA
02/2014 - 05/2002
11AntibodiesIBA
10/2015 - 07/2003
10Cancer VaccinesIBA
05/2017 - 12/2004
9VaccinesIBA
05/2017 - 02/2004
9EpitopesIBA
10/2015 - 05/2003
8Neoplasm Antigens (Tumor Antigens)IBA
12/2016 - 11/2003
7Complementary DNA (cDNA)IBA
02/2011 - 05/2003
6EnzymesIBA
03/2014 - 03/2004
5PicibanilIBA
05/2017 - 11/2009
4Biomarkers (Surrogate Marker)IBA
12/2016 - 11/2013
4ImmunosorbentsIBA
07/2012 - 01/2005
4pullulanIBA
02/2012 - 04/2007
3AutoantibodiesIBA
10/2015 - 11/2013
3CytokinesIBA
02/2015 - 10/2008
3Monophenol Monooxygenase (Tyrosinase)IBA
03/2014 - 09/2012
3Monatide (IMS 3015)IBA
02/2014 - 12/2011
3N-propionyl-4-S-cysteaminylphenolIBA
01/2013 - 07/2012
3CholesterolIBA
02/2012 - 04/2007
3Immunoglobulin G (IgG)IBA
10/2009 - 01/2004
3MacrolidesIBA
11/2008 - 10/2005
3Anti-Bacterial Agents (Antibiotics)IBA
11/2008 - 10/2005
3Monoclonal AntibodiesIBA
08/2008 - 08/2002
2LigandsIBA
12/2016 - 01/2015
2Cysteine (L-Cysteine)FDA Link
10/2015 - 09/2012
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2014 - 05/2003
2gag Gene Products (gag Protein)IBA
11/2013 - 11/2008
2SulfurIBA
01/2013 - 09/2012
2AminesIBA
01/2013 - 09/2012
2Tyrosine (L-Tyrosine)FDA Link
01/2013 - 09/2012
2Indicators and Reagents (Reagents)IBA
11/2012 - 02/2011
2Neutralizing AntibodiesIBA
02/2012 - 02/2010
2Rabies Vaccines (Rabies Vaccine)FDA Link
05/2010 - 02/2010
2Histocompatibility Antigens Class IIBA
07/2009 - 08/2008
2Minocycline (Cyclops)FDA LinkGeneric
10/2007 - 12/2006
2Protein Isoforms (Isoforms)IBA
03/2007 - 11/2005
2PC61 monoclonal antibodyIBA
11/2003 - 08/2002
1Carboxymethylcellulose Sodium (Polycell)FDA Link
05/2017
1poly ICLCIBA
05/2017
1Lysine (L-Lysine)FDA Link
05/2017
1Poly I-CIBA
05/2017
1Iodide Peroxidase (Deiodinase)IBA
10/2015
1mogamulizumabIBA
10/2015
1dorsomorphinIBA
02/2015
1AMP-Activated Protein KinasesIBA
02/2015
1Metformin (Glucophage)FDA LinkGeneric
02/2015
1GemcitabineFDA Link
01/2015
1Gefitinib (Iressa)FDA Link
01/2015
1Tyrosine Kinase InhibitorsIBA
01/2015
1PlatinumIBA
10/2014
1InterferonsIBA
06/2014
1Alanine Transaminase (SGPT)IBA
06/2014
1Viral AntigensIBA
06/2014
1RNA (Ribonucleic Acid)IBA
06/2014
1Cathepsin BIBA
03/2014
1Dextrans (Dextran)FDA Link
03/2014
1Cytochalasin BIBA
03/2014
1InflammasomesIBA
03/2014
14-nitrophenoxycarbonyl methyl disulfideIBA
03/2014
1maleimideIBA
03/2014
1N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA
03/2014
1Immunoglobulins (Immunoglobulin)IBA
12/2013
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2013
1Protein Subunit VaccinesIBA
01/2013

Therapy/Procedure

14Immunotherapy
06/2017 - 02/2004
5Drug Therapy (Chemotherapy)
10/2014 - 04/2006
3Liver Transplantation
06/2014 - 12/2013
2Injections
09/2012 - 07/2012
1Transplantation
06/2014